Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: A systematic review employing meta-analysis

European Journal of Clinical Pharmacology

Volumn 71, Issue 1, 2015, Pages 107-115

  Wang, Yan ^a   Zou, Yamin ^a   Xie, Jiao ^a   Wang, Taotao ^a   Zheng, Xiaowei ^a   He, Hairong ^a   Dong, Weihua ^a   Xing, Jianfeng ^a   Dong, Yalin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; VANCOMYCIN; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; OXAZOLIDINONE DERIVATIVE;

ARTICLE; BACTERIAL CLEARANCE; COCHRANE LIBRARY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EMBASE; HEPATITIS; HOSPITAL INFECTION; HUMAN; MEDLINE; META ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS NOSOCOMIAL PNEUMONIA; MORTALITY; NAUSEA; NEPHROTOXICITY; PANCREATITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STAPHYLOCOCCAL PNEUMONIA; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING; CROSS INFECTION; DRUG EFFECTS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA; STAPHYLOCOCCAL INFECTIONS;

ACETAMIDES; ANTI-BACTERIAL AGENTS; CROSS INFECTION; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OXAZOLIDINONES; PNEUMONIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84920194409     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-014-1775-x     Document Type: Article

References (36)

1. Edwards JR, Peterson KD, Andrus ML, Dudeck MA, Pollock DA, Horan TC, National Healthcare Safety Network F (2008) National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control 36(9):609-626
2. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, Investigators EIGo (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302(21):2323-2329
3. Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Patel PR, Fridkin SK, Active Bacterial Core surveillance MIotEIP (2010) Health care-associated invasive MRSA infections, 2005-2008. JAMA 304(6):641-648
4. Vardakas KZ, Matthaiou DK, Falagas ME (2009) Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia. Eur Respir J 34(5):1148-1158
5. Wang F, Zhu DM, Hu FP, Zhang YY (2001) Surveillance of bacterial resistance among isolates in Shanghai in 1999. J Infect Chemother 7(2):117-120
6. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274(8):639-644
7. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36(1):53-59
8. Shorr AF, Combes A, Kollef MH, Chastre J (2006) Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy. Crit Care Med 34(3):700-706
9. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y (2005) The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26(2):166-174
10. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH (2003) Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124(5):1789-1797
11. Peyrani P, Wiemken TL, Kelley R, Zervos MJ, Kett DH, File TM Jr, Stein GE, Ford KD, Scerpella EG, Welch V, Ramirez JA (2014) Higher clinical success in patients with ventilator-associated pneumonia due tomethicillin-resistant Staphylococcus aureus treated with linezolid comparedwith vancomycin: results fromthe IMPACT-HAP study. Crit Care 18(3):R118
12. Powers JH, Ross DB, Lin D, Soreth J (2004) Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses. Chest 126(1):314-315, author reply 315-316
13. Kalil AC, Puumala SE, Stoner J (2004) Unresolved questions with the use of linezolid vs vancomycin for nosocomial pneumonia. Chest 125(6):2370-2371
14. Walkey AJ, O'Donnell MR, Wiener RS (2011) Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials. Chest 139(5):1148-1155
15. Kalil AC, Klompas M, Haynatzki G, Rupp ME (2013) Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis. BMJ Open 3(10):e003912
16. Kalil AC, Murthy MH, Hermsen ED, Neto FK, Sun J, Rupp ME (2010) Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis. Crit Care Med 38(9):1802-1808
17. Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, McGee WT, Reisman A, Chastre J (2012) Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 54(5):621-629
18. An MM, Shen H, Zhang JD, Xu GT, Jiang YY (2013) Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents 41(5):426-433
19. Fu J, Ye X, Chen C, Chen S (2013) The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infections. PLoS One 8(3):e58240
20. Robinson KA, Dickersin K (2002) Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. Int J Epidemiol 31(1):150-153
21. Haynes RB, Wilczynski N, McKibbon KA, Walker CJ, Sinclair JC (1994) Developing optimal search strategies for detecting clinically sound studies in MEDLINE. J Am Med Inform Assoc 1(6):447-458
22. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1-12
23. Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B (2002) Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 34(11):1481-1490
24. Rubinstein E, Cammarata S, Oliphant T, Wunderink R (2001) Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin Infect Dis 32(3):402-412
25. Kaplan SL, Deville JG, Yogev R, Morfin MR, Wu E, Adler S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB (2003) Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J 22(8):677-686
26. Wunderink RG, Cammarata SK, Oliphant TH, Kollef MH (2003) Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin Ther 25(3):980-992
27. Jaksic B, Martinelli G, Perez-Oteyza J, Hartman CS, Leonard LB, Tack KJ (2006) Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer. Clin Infect Dis 42(5):597-607
28. Kohno S, Yamaguchi K, Aikawa N, Sumiyama Y, Odagiri S, Aoki N, Niki Y, Watanabe S, Furue M, Ito T, Croos-Dabrera R, Tack KJ (2007) Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. J Antimicrob Chemother 60(6):1361-1369
29. Lin DF, Zhang YY, Wu JF, Wang F, Zheng JC, Miao JZ, Zheng LY, Sheng RY, Zhou X, Shen HH, Ijzerman MM, Croos-Dabrera RV, Sheng W (2008) Linezolid for the treatment of infections caused by Gram-positive pathogens in China. Int J Antimicrob Agents 32(3):241-249
30. Wunderink RG, Mendelson MH, Somero MS, Fabian TC, May AK, Bhattacharyya H, Leeper KV Jr, Solomkin JS (2008) Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus. Chest 134(6):1200-1207
31. Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Shaw S, Kibbler C, Shulman R, Singer M, Wilson AP (2004) Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study. J Antimicrob Chemother 53(2):345-355
32. Dong HY, Xie J, Chen LH, Wang TT, Zhao YR, Dong YL (2014) Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients. Eur J Clin Microbiol Infect Dis 33(6):1029-1035
33. Shorr AF, Susla GM, Kollef MH (2004) Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin. Crit Care Med 32(1):137-143
34. Grau S, Alvarez-Lerma F, del Castillo A, Neipp R, Rubio-Terres C (2005) Cost-effectiveness analysis of the treatment of ventilator-associated pneumonia with linezolid or vancomycin in Spain. J Chemother 17(2):203-211
35. Daniel Mullins C, Kuznik A, Shaya FT, Obeidat NA, Levine AR, Liu LZ, Wong W (2006) Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Ther 28(8):1184-1198
36. De Cock E, Krueger WA, Sorensen S, Baker T, Hardewig J, Duttagupta S, Muller E, Piecyk A, Reisinger E, Resch A (2009) Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany. Infection 37(2):123-132